Neuromyelitis optica in a patient with pemphigus foliaceus

Journal of the Neurological Sciences

Volumn 319, Issue 1-2, 2012, Pages 152-155

  Salazar, R ^a   Cerghet, M ^a   Farhat, E ^a   Lim, H W ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Devic's disease; Neuromyelitis optica; Pemphigus foliaceus

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADOLESCENT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; SKIN BIOPSY; SPINAL CORD; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; BRAIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NEUROMYELITIS OPTICA; OPTIC NERVE; PEMPHIGUS; SPINAL CORD; TREATMENT OUTCOME;

EID: 84862756430     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.05.007     Document Type: Article

References (40)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107e14.
2. Huppke P, BluthnerM, Bauer O, StarkW, Reinhardt K, Huppke B, et al. Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology 2010;75:1740-4.
3. Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998;44:629-34. (Pubitemid 28477850)
4. Harada T, Ohashi T, Harada C, Yoshida K, Maguchi S, Moriwaka F, et al. A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). J Neuroophthalmol 1997;17:254-6. (Pubitemid 28016256)
5. Mok CC, Lau CS. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995;97:259-60.
6. Kister I, Gulati S, Boz C, Bergamaschi R, Piccolo G, Oger J, et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006;63:851-6. (Pubitemid 43882293)
7. Marques A. Da neuromieliteótica: contribuição clínica e etiológica. Hospital 1943;24: 49-63.
8. Williamson PM. Neuromyelitis optica following infectious mononucleosis. Proc Aust Assoc Neurol 1975;12:153-5.
9. Papais-Alvarenga, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AM, Oliveira S, de Oliveira CA Basilio, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002;73:429-35.
10. Miranda de Sousa A, Puccioni-Sohler M, Dias Borges A, Fernandez Adorno L, Papais Alvarenga M, Papis Alvarenga RM. Post-dengue neuromyelitis optica: case report of a Japanese-descendant Brazilian child. J Infect Chemother 2006;12:396e8.
11. Wilcox RA, Burrow J, Slee M, Craig J, Thyagarajan D. Neuromyelitis optica (Devic's disease) in a patient with syphilis. Mult Scler 2008;14:268e71.
12. Blanche P, Diaz E, Gombert B, Sicard D. Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 2000;68:795-6. (Pubitemid 30265290)
13. Tsubaki T, Honma Y, Hoshi M. Neurological syndrome associated with clioquinol. Lancet 1971;1:696-7.
14. Banwell B, tenemboum S, Lennon VA, Ursell E, Kennedy J, bar-Or A, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorder. Neurology 2008;70:344-52.
15. Lotze TE, Northrop JL, Hutton GJ, Ross B, schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039-47.
16. Oktarina DA, van derWier G, Diercks GF, Jonkman MF, Pas HH. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol Sep 2011;165(3):552-62.
17. Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol Mar 2012;132:776-84.
18. Grando SA, Holubar K, Schwartz RA. Jean-Claude Bystryn 1938-2010. An obituary. Exp Dermatol Mar 2011;20(3):293-6.
19. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106e12.
20. Tait MJ, saadoun S, Bell BA, Papadopoulos MC. Water movements in the brain: role of aquaporins. Trends Neurosci 2008;31(1):37-43.
21. Hara-Chikuma M, Verkman AS. Aquaporin-3 functions as a glycerol transporter in mammalian skin. Biol Cell 2005;97:479-86. (Pubitemid 40936590)
22. Boury-Jamot M, Daraspe J, Bonte F, Perrier E, Schnebert S, Dumas M, et al. Skin aquaporins: function in hydration, wound healing and skin epidermis homeostasis. Handb Exp Pharmacol 2009;190:205-17.
23. Hara-Chikuma M, Verkman AS. Roles of aquaporin-3 in the epidermis. J Invest Dermatol Sep 2008;128(9):2145-51.
24. Suárez-Fariñas M, Fuentes-Duculan J, Lowes MA, Krueger JG. Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol Feb 2011;131(2):391-400.
25. Hara-Chikuma M, Sugiyama Y, Kabashima K, Sohara E, Uchida S, Sasaki S, et al. Involvement of aquaporin-7 in the cutaneous primary immune response through modulation of antigen uptake and migration in dendritic cells. FASEB J Jan 2012;26(1):211-8.
26. Hara-Chikuma M, Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med 2008;86:221-31. (Pubitemid 351172129)
27. Ma T, Hara M, Sougrat R, Verbavatz JM, Verkman AS. Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. J Biol Chem 2002;277:17147-53. (Pubitemid 34967747)
28. Marchini G, Ståbi B, Kankes K, Lonne-Rahm S, Østergaard M, Nielsen S. AQP1 and AQP3, psoriasin, and nitric oxide synthases 1-3 are inflammatory mediators in erythema toxicum neonatorum. Pediatr Dermatol 2003;20(5):377-84. (Pubitemid 37280478)
29. Straseski JA, Gibson AL, Thomas-Virnig CL, Allen-Hoffmann BL. Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen. Wound Repair Regen 2009;17(4): 606-16.
30. Matsuya N, Komori M, Nomura K, Nakane S, Fukudome T, Goto H, et al. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica. Int Immunol 2011;23(9):565-73.
31. Kim W, Kim SH, Kim HJ. New insights into neuromyelitis optica. J Clin Neurol 2011;7(3):115-27.
32. Pohl M, Fischer MT, Mader S, Schanda K, Kitic M, Sharma R, et al. Pathogenic T cell responses against aquaporin 4. Acta Neuropathol Jul 2011;122(1):21-34.
33. Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol Jan 2000;114(1):88-94. (Pubitemid 30195978)
34. Wada N, Nishifuji K, Yamada T, Kudoh J, Shimizu N, Matsumoto M, et al. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance. J Invest Dermatol Feb 2011;131(2):410-7.
35. Culton DA, Qian Y, Li N, Rubenstein D, Aoki V, Filhio GH, et al. Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun Dec 2008;31(4):311-24.
36. Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol Nov 2006;142(11):1447-54. (Pubitemid 44790638)
37. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256e9.
38. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist Jan 2007;13(1):2-11. (Pubitemid 46095579)
39. Herr AL, Hatami A, Kokta V, Dalle JH, Champagne MA, Duval M. Successful anti- CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transplant Feb 2005;35(4):427-8. (Pubitemid 40309494)
40. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, et al. Treatment of neuromyelitis optic with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008;65:1443e8.